A Possible Distinct Molecular Subtype (Quintuple-Wildtype) of Metastatic Colorectal Cancer in First-Line Anti-EGFR Therapy with Cetuximab Plus FOLFIRI - Palliative Precision Therapy and a Multidisciplinary Treatment Approach: Interim Analysis of the IVOPAK II Trial with Early Results.
Saved in:
| Title: | A Possible Distinct Molecular Subtype (Quintuple-Wildtype) of Metastatic Colorectal Cancer in First-Line Anti-EGFR Therapy with Cetuximab Plus FOLFIRI - Palliative Precision Therapy and a Multidisciplinary Treatment Approach: Interim Analysis of the IVOPAK II Trial with Early Results. |
|---|---|
| Authors: | Wein A; Department of Internal Medicine 1, Gastroenterology, Pulmonology, and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Stoehr R; Department of Pathology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Kersting S; Department of Surgery, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.; Department of Surgery, University of Greifswald, Greifswald, Germany., Siebler J; Department of Internal Medicine 1, Gastroenterology, Pulmonology, and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Merkel S; Department of Surgery, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Busse D; Department of Internal Medicine 1, Gastroenterology, Pulmonology, and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Wolff K; Department of Internal Medicine 1, Gastroenterology, Pulmonology, and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Ostermeier N; Department of Internal Medicine 1, Gastroenterology, Pulmonology, and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Neufert C; Department of Internal Medicine 1, Gastroenterology, Pulmonology, and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Vitali F; Department of Internal Medicine 1, Gastroenterology, Pulmonology, and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Eckstein M; Department of Pathology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Roth JP; Department of Radiology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Anhut P; Medical Practice of Oncology, Kronach, Germany., Schreiner W; Department of Surgery, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Uder M; Department of Radiology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Hartmann A; Department of Pathology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Neurath MF; Department of Internal Medicine 1, Gastroenterology, Pulmonology, and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Grützmann R; Department of Surgery, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany. |
| Source: | Oncology [Oncology] 2022; Vol. 100 (1), pp. 1-11. Date of Electronic Publication: 2021 Oct 20. |
| Publication Type: | Clinical Trial, Phase II; Journal Article |
| Journal Info: | Publisher: Karger Country of Publication: Switzerland NLM ID: 0135054 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-0232 (Electronic) Linking ISSN: 00302414 NLM ISO Abbreviation: Oncology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34670215 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A Possible Distinct Molecular Subtype (Quintuple-Wildtype) of Metastatic Colorectal Cancer in First-Line Anti-EGFR Therapy with Cetuximab Plus FOLFIRI - Palliative Precision Therapy and a Multidisciplinary Treatment Approach: Interim Analysis of the IVOPAK II Trial with Early Results. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wein+A%22">Wein A</searchLink>; Department of Internal Medicine 1, Gastroenterology, Pulmonology, and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Stoehr+R%22">Stoehr R</searchLink>; Department of Pathology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Kersting+S%22">Kersting S</searchLink>; Department of Surgery, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.; Department of Surgery, University of Greifswald, Greifswald, Germany.<br /><searchLink fieldCode="AU" term="%22Siebler+J%22">Siebler J</searchLink>; Department of Internal Medicine 1, Gastroenterology, Pulmonology, and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Merkel+S%22">Merkel S</searchLink>; Department of Surgery, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Busse+D%22">Busse D</searchLink>; Department of Internal Medicine 1, Gastroenterology, Pulmonology, and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Wolff+K%22">Wolff K</searchLink>; Department of Internal Medicine 1, Gastroenterology, Pulmonology, and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Ostermeier+N%22">Ostermeier N</searchLink>; Department of Internal Medicine 1, Gastroenterology, Pulmonology, and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Neufert+C%22">Neufert C</searchLink>; Department of Internal Medicine 1, Gastroenterology, Pulmonology, and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Vitali+F%22">Vitali F</searchLink>; Department of Internal Medicine 1, Gastroenterology, Pulmonology, and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Eckstein+M%22">Eckstein M</searchLink>; Department of Pathology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Roth+JP%22">Roth JP</searchLink>; Department of Radiology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Anhut+P%22">Anhut P</searchLink>; Medical Practice of Oncology, Kronach, Germany.<br /><searchLink fieldCode="AU" term="%22Schreiner+W%22">Schreiner W</searchLink>; Department of Surgery, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Uder+M%22">Uder M</searchLink>; Department of Radiology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Hartmann+A%22">Hartmann A</searchLink>; Department of Pathology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Neurath+MF%22">Neurath MF</searchLink>; Department of Internal Medicine 1, Gastroenterology, Pulmonology, and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Grützmann+R%22">Grützmann R</searchLink>; Department of Surgery, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220135054%22">Oncology</searchLink> [Oncology] 2022; Vol. 100 (1), pp. 1-11. <i>Date of Electronic Publication: </i>2021 Oct 20. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Karger%22">Karger </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>0135054 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1423-0232 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200302414%22">00302414 </searchLink><i>NLM ISO Abbreviation: </i>Oncology <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34670215 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1159/000519252 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1 Titles: – TitleFull: A Possible Distinct Molecular Subtype (Quintuple-Wildtype) of Metastatic Colorectal Cancer in First-Line Anti-EGFR Therapy with Cetuximab Plus FOLFIRI - Palliative Precision Therapy and a Multidisciplinary Treatment Approach: Interim Analysis of the IVOPAK II Trial with Early Results. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wein A – PersonEntity: Name: NameFull: Stoehr R – PersonEntity: Name: NameFull: Kersting S – PersonEntity: Name: NameFull: Siebler J – PersonEntity: Name: NameFull: Merkel S – PersonEntity: Name: NameFull: Busse D – PersonEntity: Name: NameFull: Wolff K – PersonEntity: Name: NameFull: Ostermeier N – PersonEntity: Name: NameFull: Neufert C – PersonEntity: Name: NameFull: Vitali F – PersonEntity: Name: NameFull: Eckstein M – PersonEntity: Name: NameFull: Roth JP – PersonEntity: Name: NameFull: Anhut P – PersonEntity: Name: NameFull: Schreiner W – PersonEntity: Name: NameFull: Uder M – PersonEntity: Name: NameFull: Hartmann A – PersonEntity: Name: NameFull: Neurath MF – PersonEntity: Name: NameFull: Grützmann R IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2022 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1423-0232 Numbering: – Type: volume Value: 100 – Type: issue Value: 1 Titles: – TitleFull: Oncology Type: main |
| ResultId | 1 |